Meet the project leadership team!

Introducing the c4c project leadership team: Carlo Giaquinto (Penta – project coordinator) Mark Turner (University of Liverpool – co-coordinator) Katharine Cheng (Janssen – project lead) Heidrun Hildebrand (Bayer – co-project lead). We lead and supervise the overall progress of c4c, with the support of the project management office, and by working closely with Work Package…

What are patients’ needs and how to improve the development of medicines?

What are patients’ needs and how to improve the development of medicines?  First c4c Multi-Stakeholder Meeting on paediatric Inflammatory Bowel Disease (IBD).  c4c held its first International Multi-Stakeholder Meeting (MSM) on paediatric Inflammatory Bowel Disease (IBD) virtually on 14-15 April 2021. Over 100 individuals participated, representing patients and advocates, clinicians, academics, pharmaceutical companies and regulators.…

National Hub meeting outcomes

c4c held the first workshop on Young Persons Advocacy Groups (YPAG) for the PPI liaisons in the National Hubs on the 28 January and 4 February held over ZOOM virtual meeting platform. In case you are not familiar with this term, A Young Persons Advisory Group (YPAG) is a group made up of children and…

IMI publishes articles about c4c progess

IMI publishes articles about the progress of c4c and closing the gap in paediatric medicine development   The Innovative Medicines Initiative (IMI) who provide grant funding for conect4children, have published an article about the important work c4c has carried out so far, to ensure that clinical trial sites across Europe are ‘trial ready’ for paediatric…